These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10774796)

  • 1. Ischemia-induced action potential shortening is blunted by d-sotalol in a pig model of reversible myocardial ischemia.
    Geelen P; O'Hara GE; Plante S; Philippon F; Gilbert M; Turgeon J
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):638-45. PubMed ID: 10774796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.
    MacKenzie I; Saville VL; Waterfall JF
    Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proarrhythmic effects of DL- and D-sotalol on the "border zone" between normal and ischemic regions of isolated ventricular myocardium and antiarrhythmic effects on reperfusion.
    Picard S; Rouet R; Monti F; Puddu PE; Ducouret P; Flais F; Libersa C; Gérard JL
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):126-39. PubMed ID: 9456287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate and time dependent effects of D-sotalol on the monophasic action potential after sudden increase of the heart rate.
    Melichercik J; Brachmann J; Schöls W; Hilbel T; Beyer T; Kübler W
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):65-72. PubMed ID: 9990602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium abolishes inadequate kinetics of frequency adaptation of the Q-aT interval in the presence of sotalol.
    Stark G; Schwarzl I; Heiden U; Stark U; Tritthart HA
    Cardiovasc Res; 1997 Jul; 35(1):43-51. PubMed ID: 9302346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro- and antiarrhythmic effects of d-sotalol and dl-sotalol in an isolated tissue model of ischemia and reperfusion.
    Pasnani JS; Ferrier GR
    J Pharmacol Exp Ther; 1994 Oct; 271(1):184-92. PubMed ID: 7965713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic actions of d,l-sotalol and GLG-V-13 in ischemically injured canine epicardium.
    Patterson E; Scherlag BJ; Lazzara R; Garrison GL; Berlin KD
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):304-13. PubMed ID: 17878760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits.
    Baczkó I; El-Reyani NE; Farkas A; Virág L; Iost N; Leprán I; Mátyus P; Varró A; Papp JG
    Eur J Pharmacol; 2000 Sep; 404(1-2):181-90. PubMed ID: 10980278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol.
    Merot J; Charpentier F; Poirier JM; Coutris G; Weissenburger J
    Cardiovasc Res; 1999 Nov; 44(2):303-14. PubMed ID: 10690307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute global low-flow ischemia on triggered arrhythmias in d-sotalol-induced long Q-T intervals in perfused rabbit hearts.
    Spear JF; Moore EN
    J Cardiovasc Pharmacol; 2001 Feb; 37(2):196-208. PubMed ID: 11210002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
    Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical heterogeneity and arrhythmogenesis: importance of conduction velocity dispersion.
    Sims JJ; Miller AW; Ujhelyi MR
    J Cardiovasc Pharmacol; 2003 May; 41(5):795-803. PubMed ID: 12717112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents.
    Vanoli E; Priori SG; Nakagawa H; Hirao K; Napolitano C; Diehl L; Lazzara R; Schwartz PJ
    J Am Coll Cardiol; 1995 Jun; 25(7):1609-14. PubMed ID: 7759713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.
    Frommeyer G; Milberg P; Witte P; Stypmann J; Koopmann M; Lücke M; Osada N; Breithardt G; Fehr M; Eckardt L
    Eur J Heart Fail; 2011 Oct; 13(10):1060-9. PubMed ID: 21873342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lignocaine on dispersion of repolarisation and refractoriness in a working rabbit heart model of regional myocardial ischaemia.
    Wolk R; Cobbe SM; Hicks MN; Kane KA
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):253-61. PubMed ID: 9475267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol.
    Fiset C; Drolet B; Hamelin BA; Turgeon J
    J Pharmacol Exp Ther; 1997 Oct; 283(1):148-56. PubMed ID: 9336319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
    Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms.
    Mori K; Hara Y; Saito T; Masuda Y; Nakaya H
    Circulation; 1995 Jun; 91(11):2834-43. PubMed ID: 7758191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: a comparison between almokalant and d-sotalol using the dog as its own control.
    Verduyn SC; Vos MA; van der Zande J; Kulcsàr A; Wellens HJ
    J Am Coll Cardiol; 1997 Nov; 30(6):1575-84. PubMed ID: 9362418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.